ENDRA Life Sciences Operating Cash Flow 2011-2026 | NDRA

Annual Operating Cash Flow ENDRA Life Sciences

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-7.4 M	-9.55 M	-12.8 M	-11.1 M	-10.7 M	-8.59 M	-7.7 M	-3.3 M	-1.32 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.32 M	-12.8 M	-8.06 M

Quarterly Operating Cash Flow ENDRA Life Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-1.29 M	-	-	-	-2.14 M	-	-	-	-2.51 M	-	-9.68 M	-6.43 M	-3.1 M	-	-8.47 M	-5.72 M	-2.92 M	-	-8.67 M	-6.54 M	-3.09 M	-	-6.68 M	-4.2 M	-2.54 M	-	-5.8 M	-4.33 M	-2.45 M	-	-1.93 M	-1.38 M	-236 K	-	-769 K	-769 K	-53.8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-53.8 K	-9.68 M	-3.82 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	74.7 M	$ 8.96	1.01 %	$ 597 M	USA
Brainsway Ltd. BWAY	884 K	$ 13.67	0.15 %	$ 99.4 M	Israel
Aspira Women's Health AWH	-32.2 M	-	-6.19 %	$ 10.5 M	USA
Castle Biosciences CSTL	64.9 M	$ 25.94	0.43 %	$ 721 M	USA
DexCom DXCM	1.44 B	$ 68.13	2.7 %	$ 26.6 B	USA
Charles River Laboratories International CRL	738 M	$ 154.1	1.4 %	$ 7.64 B	USA
CareDx, Inc CDNA	42 M	$ 17.47	0.87 %	$ 931 M	USA
Guardant Health GH	-185 M	$ 88.35	1.34 %	$ 11.1 B	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	491 M	$ 103.93	0.08 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	21.1 M	$ 15.57	4.11 %	$ 471 M	USA
IQVIA Holdings IQV	2.65 B	$ 168.8	2.43 %	$ 29 B	USA
Biodesix BDSX	-48.6 M	$ 17.35	0.35 %	$ 2.25 B	USA
ICON Public Limited Company ICLR	1.29 B	$ 99.75	2.19 %	$ 8.23 B	Irlanda
Anixa Biosciences ANIX	-7.17 M	$ 2.86	0.7 %	$ 92.8 K	USA
Danaher Corporation DHR	6.42 B	$ 195.49	2.14 %	$ 139 B	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	837 M	$ 122.2	2.45 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 199.41	0.23 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	674 M	-	-	$ 10.6 B	Niderland
Agilent Technologies A	1.48 B	$ 113.82	1.78 %	$ 34.6 B	USA
BioNano Genomics BNGO	-68.9 M	$ 1.13	1.35 %	$ 1.44 M	USA
DarioHealth Corp. DRIO	-30.4 M	$ 9.02	7.13 %	$ 256 M	Israel
NeoGenomics NEO	5.23 M	$ 8.31	0.85 %	$ 1.06 B	USA
Neogen Corporation NEOG	58.2 M	$ 9.26	1.59 %	$ 2.01 B	USA
Lantheus Holdings LNTH	390 M	$ 79.31	1.03 %	$ 5.35 B	USA
Pacific Biosciences of California PACB	-111 M	$ 1.42	4.04 %	$ 426 M	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	-22.1 M	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	713 M	$ 454.33	0.15 %	$ 13.1 B	USA
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	956 M	$ 1 219.09	1.66 %	$ 25.1 B	Schweiz
Celcuity CELC	-83.5 M	$ 114.35	-0.48 %	$ 4.51 B	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	26.4 M	$ 17.74	1.95 %	$ 397 M	USA
Invitae Corporation NVTA	-493 M	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	-432 M	$ 200.3	1.33 %	$ 19.7 B	USA
OPKO Health OPK	-183 M	$ 1.2	0.42 %	$ 833 M	USA